insights_auto
Why is HQY down 2.70%?
Dive Deeperchevron_right
HQY:NASDAQ
Healthequity Inc
$94.75
arrow_downward
-2.70%(-2.63) 1D
$94.75
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 20, 4:00:02 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HQY...
Open
$97.66
High
$99.46
Low
$94.37
Mkt. cap
7.84B
Avg. vol.
804.81K
Volume
741.34K
P/E ratio
34.24
52-wk high
$110.26
52-wk low
$72.76
EPS
$2.77
Beta
0.22
Shares outstanding
82.72M
No. of employees
3K
Open
$97.66
High
$99.46
Low
$94.37
Mkt. cap
7.84B
Avg. vol.
804.81K
Volume
741.34K
P/E ratio
34.24
52-wk high
$110.26
52-wk low
$72.76
EPS
$2.77
Beta
0.22
Shares outstanding
82.72M
No. of employees
3K
News stories
From web sources and news partners
Zacks
·
1 day ago
Here's Why HealthEquity (HQY) is a Strong Value Stock
Profile
HealthEquity, Inc. is an American financial technology and business services company that is designated as a non-bank health savings trustee by the IRS. This designation allows HealthEquity to be the custodian of health savings accounts regardless of which financial institution the funds are deposited with.
As of July 31, 2022, HealthEquity managed 7.5 million HSA accounts, plus 7 million other consumer-directed benefits for total accounts of 14.5 million. Total HSA assets as of July 31, 2022 were $20.5 billion, including $13.1 billion of HSA cash and $7.4 billion of HSA investments. Wikipedia
About Healthequity Inc
CEOJon Kessler
Employees2.81K
FoundedJan 1, 2002
HeadquartersDraper, Utah, United States
SectorHealth Care
IndustryHealth care provider
Websitehealthequity.com
Analyst ratings
Based on 8 analysts giving stock ratings to HQY in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for HQY in the last 3 months.
Highest
Current $94.75
$142.00 (+49.87%)
Average
$120.63 (+27.31%)
Lowest
$108.00 (+13.98%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Sean Dodge BMO Capital | Buy | Reiterated | $125.00 | +31.9% | 10/21/2026 |
Allen Lutz Bank of America Securities | Buy | Maintained | $125.00 | +31.9% | 10/16/2026 |
Ryan Halsted RBC Capital | Buy | Maintained | $108.00 | +14% | 10/06/2026 |
Stan Berenshteyn Wells Fargo | Buy | Reiterated | $125.00 | +31.9% | 09/29/2026 |
Peter Warendorf Barclays | Buy | Reiterated | $115.00 | +21.4% | 09/18/2026 |
George Hill Deutsche Bank | Buy | Reiterated | $142.00 | +49.9% | 08/31/2026 |
Alexander Paris Barrington | Buy | Reiterated | $110.00 | +16.1% | 08/28/2026 |
David Larsen BTIG | Buy | Maintained | $115.00 | +21.4% | 08/28/2026 |
Scott Schoenhaus KeyBanc | Buy | Maintained | $125.00 | +31.9% | 08/18/2026 |
Alexei Gogolev J.P. Morgan | Buy | Reiterated | $123.00 | +29.8% | 06/25/2026 |
Constantine Davides Citizens JMP | Buy | Maintained | $111.00 | +17.2% | 06/01/2026 |
David Roman Goldman Sachs | Sell | Maintained | $88.00 | -7.1% | 05/29/2026 |
Daniel Perlin RBC Capital | Buy | Reiterated | $100.00 | +5.5% | 03/17/2026 |
Brian Tanquilut Jefferies | Buy | Maintained | $108.00 | +14% | 02/19/2026 |
Gregory Peters Raymond James | Buy | Reiterated | $100.00 | +5.5% | 02/17/2026 |
Next call in 10 days
Tue, Dec 1, 4:30 PM
Fiscal period
Q3 2027
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $1.15
Revenue / Est. (USD)
- / 347.26M
Fiscal Q3 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
Revenue | 322.16M | 334.59M | 354.64M | 350.73M |
Cost of goods sold | 94.10M | 106.44M | 98.33M | 92.78M |
Cost of revenue | 94.10M | 106.44M | 98.33M | 92.78M |
Research and development expenses | 65.92M | 70.35M | 67.77M | 73.92M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 55.29M | 58.45M | 57.96M | 58.08M |
Operating expense | 148.21M | 155.75M | 152.25M | 158.29M |
Total operating expenses | 242.31M | 262.19M | 250.58M | 251.07M |
Operating income | 79.85M | 72.40M | 104.07M | 99.66M |
Other non operating income | 22.00K | 329.00K | 161.00K | 20.00K |
EBT including unusual items | 67.53M | 60.90M | 92.41M | 87.86M |
EBT excluding unusual items | 68.69M | 62.22M | 93.53M | 88.84M |
Income tax expense | 15.84M | 11.16M | 23.00M | 22.22M |
Effective tax rate | 23.46% | 18.32% | 24.88% | 25.29% |
Other operating expenses | - | - | - | - |
Net income | 51.69M | 49.74M | 69.42M | 65.64M |
Net profit margin | 16.05% | 14.87% | 19.57% | 18.72% |
Earnings per share | 1.01 | 0.95 | 1.24 | 1.24 |
Interest and investment income | 2.86M | 2.77M | 1.89M | 1.76M |
Interest expense | -14.05M | -13.27M | -12.59M | -12.60M |
Net interest expenses | -11.18M | -10.50M | -10.70M | -10.84M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 118.63M | 111.08M | 142.28M | 141.62M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events